Journal of the Neurological Sciences
Volume 238, Issue 1 , Pages 53-57 , 15 November 2005

Lymphocyte-specific protein tyrosine kinase is a novel risk gene for Alzheimer disease

  • Wangtao Zhong

      Affiliations

    • Department of Geriatric Medicine, Ehime University School of Medicine, Ehime, Japan
    • ,
  • Hidehisa D. Yamagata

      Affiliations

    • Department of Medical Genetics, Ehime University School of Medicine, National University Corporation, Touon-shi, Ehime 791-0295, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 89 960 5278; fax: +81 89 960 5279.
    • ,
  • Keiko Taguchi

      Affiliations

    • Department of Geriatric Medicine, Ehime University School of Medicine, Ehime, Japan
    • ,
  • Hiroyasu Akatsu

      Affiliations

    • Choju Medical Institute, Fukushimura Hospital, Toyohashi, Japan
    • ,
  • Kouzin Kamino

      Affiliations

    • Division of Psychiatry and Behavioral Proteomics, Department of Post-Genomics and Diseases, Osaka University Graduate School of Medicine, Suita, Japan
    • ,
  • Takayuki Yamamoto

      Affiliations

    • Choju Medical Institute, Fukushimura Hospital, Toyohashi, Japan
    • ,
  • Kenji Kosaka

      Affiliations

    • Choju Medical Institute, Fukushimura Hospital, Toyohashi, Japan
    • ,
  • Masatoshi Takeda

      Affiliations

    • Division of Psychiatry and Behavioral Proteomics, Department of Post-Genomics and Diseases, Osaka University Graduate School of Medicine, Suita, Japan
    • ,
  • Ikuko Kondo

      Affiliations

    • Department of Medical Genetics, Ehime University School of Medicine, National University Corporation, Touon-shi, Ehime 791-0295, Japan
    • ,
  • Tetsuro Miki

      Affiliations

    • Department of Geriatric Medicine, Ehime University School of Medicine, Ehime, Japan

Received 1 March 2005 ,Revised 14 June 2005 ,Accepted 18 June 2005.

References 

  1. Chandra V, Pandav R. Gene-environment interaction in Alzheimer's disease: a potential role for cholesterol. Neuroepidemiology. 1998;17:225–232
  2. Kawas CH, Katzman R. The epidemiology of dementia and Alzheimer disease. In:  Terry RD,  Katzman R,  Bick KL,  Sisodia SS editor. Alzheimer disease. 2nd ed.. Philadelphia: Lippincott Williams & Wilkins; 1999;p. 95–116
  3. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev. 2001;81:741–766
  4. McGeer EG, McGeer PL. The importance of inflammatory mechanisms in Alzheimer's disease. Exp Gerontol. 1998;33:371–378
  5. Xia MQ, Hyman BT. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J Neurovirol. 1999;5:32–41
  6. Togo T, Akiyama H, Iseki E, Kondo H, Ikeda K, Kato M, et al. Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J Neuroimmunol. 2002;124:83–92
  7. Galimberti D, Fenoglio C, Lovati C, Gatti A, Guidi I, Venturelli E, et al. CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer's disease. J Neurol Sci. 2004;225:79–83
  8. Glaichenhaus N, Shastri N, Littman DR, Turner JM. Requirement for association of p56lck with CD4 in antigen-specific signal transduction in T cells. Cell. 1991;64:511–520
  9. Veillette A, Davidson D. Src-related protein tyrosine kinases and T-cell receptor signaling. Trends Genet. 1992;8:61–66
  10. Mustelin T, Burn P. Regulation of src family tyrosine kinases in lymphocytes. Trends Biochem Sci. 1993;18:215–220
  11. Omri B, Crisanti P, Marty MC, Alliot F, Fagard R, Molina T, et al. The Lck tyrosine kinase is expressed in brain neurons. J Neurochem. 1996;67:1360–1364
  12. Van Tan H, Allee G, Benes C, Barnier JV, Vincent JD, Fagard R. Expression of a novel form of the p56lck protooncogene in rat cerebellar granular neurons. J Neurochem. 1996;67:2306–2315
  13. Hata R, Masumura M, Akatsu H, Li F, Fujita H, Nagai Y, et al. Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. Biochem Biophys Res Commun. 2001;284:310–316
  14. Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, et al. Results of a high-resolution genome screening of 437 Alzheimer's disease families. Hum Mol Genet. 2003;12:23–32
  15. Voronova AF, Adler HT, Sefton BM. Two lck transcripts containing different 5′ untranslated regions are present in T cells. Mol Cell Biol. 1987;7:4407–4413
  16. Nervi S, Nicodeme S, Gartioux C, Atlan C, Lathrop M, Reviron D, et al. No association between lck gene polymorphisms and protein level in type 1 diabetes. Diabetes. 2002;51:3326–3330
  17. Wright DD, Sefton BM, Kamps MP. Oncogenic activation of the LCK protein accompanies translocation of the LCK gene in the human HSB2 T-cell leukemia. Mol Cell Biol. 1994;14:2429–2437
  18. Nervi S, Atlan-Gepner C, Kahn-Perles B, Lecine P, Vialettes B, Imbert J, et al. Specific deficiency of p56lck expression in T lymphocytes from type 1 diabetic patients. J Immunol. 2000;165:5874–5883
  19. Matache C, Onu A, Stefanescu M, Tanaseanu S, Dragomir C, Dolganiuc A, et al. Dysregulation of p56lck kinase in patients with systemic lupus erythematosus. Autoimmunity. 2001;34:27–38
  20. Ramanathan M, Weinstock-Guttman B, Nguyen LT, Badgett D, Miller C, Patrick K, et al. In vivo gene expression revealed by cDNA arrays: the pattern in relapsing–remitting multiple sclerosis patients compared with normal subjects. J Neuroimmunol. 2001;116:213–219
  21. Romagnoli P, Strahan D, Cantagrel A, van Meerwijk JP. A potential role for protein tyrosine kinase p56(lck) in rheumatoid arthritis synovial fluid T lymphocyte hyporesponsiveness. Int Immunol. 2001;13:305–312
  22. Rouer E. Expression of the p56lck by colon tumors: a marker of their invasive capacity?. Bull Cancer. 2004;91:928–940
  23. Hulme JS, Barratt BJ, Twells RC, Cooper JD, Lowe CE, Howson JM, et al. Association analysis of the lymphocyte-specific protein tyrosine kinase (LCK) gene in type 1 diabetes. Diabetes. 2004;53:2479–2482
  24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939–944
  25. Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198
  26. Matsubara M, Yamagata H, Kamino K, Nomura T, Kohara K, Kondo I, et al. Genetic association between Alzheimer disease and the alpha-synuclein gene. Dement Geriatr Cogn Disord. 2001;12:106–109
  27. Akatsu H, Takahashi M, Matsukawa N, Ishikawa Y, Kondo N, Sato T, et al. Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital. J Neurol Sci. 2002;196:63–69
  28. Sambrook J, Fritsch EF, Maniatis T. In: Molecular cloning: a laboratory manual. 2nd ed.. New York: Cold Spring Harbor Laboratory Press; 1989;p. 9.14–9.19
  29. Muise-Helmericks RC, Rosen N. Identification of a novel repressive element in the proximal lck promoter. J Biol Chem. 1995;270:27538–27543
  30. Hunter T. A thousand and one protein kinases. Cell. 1987;50:823–829
  31. Cotton PC, Brugge JS. Neural tissues express high levels of the cellular src gene product pp60c-src. Mol Cell Biol. 1983;3:1157–1162
  32. Salter MW. Src, N-methyl-d-aspartate (NMDA) receptors, and synaptic plasticity. Biochem Pharmacol. 1998;56:789–798
  33. Grant SG, O'Dell TJ, Karl KA, Stein PL, Soriano P, Kandel ER. Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science. 1992;258:1903–1910
  34. Yagi T. Scr family kinases control neural development and function. Dev Growth Differ. 1994;36:543–550
  35. Ali DW, Salter MW. NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity. Curr Opin Neurobiol. 2001;11:336–342
  36. Lu YM, Roder JC, Davidow J, Salter MW. Src activation in the induction of long-term potentiation in CA1 hippocampal neurons. Science. 1998;279:1363–1367
  37. Yu XM, Askalan R, Keil GJ, Salter MW. NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science. 1997;275:674–678
  38. Sattler R, Xiong Z, Lu WY, Hafner M, MacDonald JF, Tymianski M. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science. 1999;284:1845–1848

PII: S0022-510X(05)00262-5

doi: 10.1016/j.jns.2005.06.017

Journal of the Neurological Sciences
Volume 238, Issue 1 , Pages 53-57 , 15 November 2005

Article Tools